Immunotherapy Treatment Shows Promise for Resectable Liver Cancer Immunotherapy Treatment Shows Promise for Resectable Liver Cancer
Perioperative immunotherapy appears to be safe in the setting of resectable hepatocellular carcinoma, according to findings from an open-label phase 2 clinical trial.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Hematology | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Urology & Nephrology